Peptostreptococcus infection – Basic Information

Go back

Peptostreptococcus infection occurs when bacteria that normally live peacefully in our bodies turn harmful, causing illnesses ranging from mild throat infections to severe, life-threatening conditions. These tiny, round bacteria are part of our everyday microbial community but can become dangerous under certain circumstances, making understanding them essential for proper care and prevention.

Understanding Peptostreptococcus Bacteria

Peptostreptococcus bacteria are small, spherical microorganisms that belong to a special group called anaerobic bacteria, which means they thrive in environments without oxygen. These bacteria typically appear in pairs, short chains, or individually when viewed under a microscope. They are classified as gram-positive cocci, measuring between 0.3 and 1.8 micrometers in diameter depending on the specific species.[6]

What makes Peptostreptococcus particularly challenging is that these bacteria are slow-growing and have developed increasing resistance to certain antimicrobial drugs over time. The genus includes several species, with the most commonly identified being Peptostreptococcus magnus (now reclassified as Finegoldia magna), Peptostreptococcus asaccharolyticus, Peptostreptococcus anaerobius, Peptostreptococcus prevotii, and Peptostreptococcus micros.[2][3]

Where These Bacteria Live

Under normal circumstances, Peptostreptococcus species are commensal organisms, meaning they live on and in our bodies without causing harm. In fact, they are considered part of the normal, healthy bacterial population. These bacteria predominantly inhabit the mouth, skin, gastrointestinal tract, vagina, and urinary tracts, where they exist peacefully alongside other microorganisms as part of the body’s natural microbial community.[2][6]

Peptostreptococcus is even recognized as a normal inhabitant of the healthy lower reproductive tract in women. The bacteria are found worldwide as part of the normal human microbial flora, making them universal companions to human health. These organisms have also been isolated from various animals, including rats, mice, cats, dogs, monkeys, and rabbits, suggesting they are widespread in the animal kingdom as well.[6]

How Common Are These Infections

Peptostreptococcus infections represent a significant portion of bacterial infections involving anaerobic organisms. Anaerobic gram-positive cocci such as Peptostreptococcus are the second most frequently recovered anaerobes in clinical settings, accounting for approximately one quarter of all anaerobic isolates found.[2][3]

These bacteria are isolated with high frequency from all specimen sources in medical laboratories. In cases of bacteremia in adults, anaerobes are reported to cause between 8 and 11 percent of cases, and peptostreptococci account for 25 to 30 percent of all anaerobic isolates recovered from blood infections.[6]

It’s important to understand that Peptostreptococcus bacteria are usually recovered mixed with other anaerobic or aerobic bacteria from various infections at different sites throughout the body. This mixing with other organisms contributes to the difficulty of isolating and identifying Peptostreptococcus organisms specifically, as they rarely act alone in causing disease.[2]

Causes and How Infections Develop

Peptostreptococcus infections occur when these normally harmless bacteria gain access to parts of the body where they shouldn’t be, or when conditions change to favor their harmful behavior. The transformation from peaceful inhabitant to disease-causing agent typically happens under specific circumstances that compromise the body’s natural defenses.[2]

Infection is usually associated with trauma or disease. When the body experiences physical injury that breaks the skin or damages internal tissues, these bacteria can enter deeper layers where they don’t belong. Similarly, when someone has an underlying disease that weakens the immune system, the bacteria can take advantage of the body’s reduced ability to keep them in check.[6]

Under immunosuppressed or traumatic conditions, these organisms can become pathogenic (disease-causing), as well as septicemic (causing blood poisoning), thereby harming their host. The bacteria participate in what are called mixed anaerobic infections, a term used to describe infections caused by multiple bacteria that do not require oxygen or may even be harmed by it.[2]

⚠️ Important
Most Peptostreptococcus infections don’t occur in isolation. These bacteria typically work together with other organisms in what doctors call synergistic infections, where different bacteria enhance each other’s ability to cause disease. This means treating these infections often requires addressing multiple types of bacteria simultaneously, not just Peptostreptococcus alone.

Risk Factors for Infection

Certain groups of people and specific situations increase the likelihood of developing a Peptostreptococcus infection. Peptostreptococcus infections occur more often in chronic infections and in association with particular predisposing conditions that create opportunities for these bacteria to cause disease.[1]

People with weakened immune systems are at higher risk, as their bodies have reduced capacity to control the normal bacterial populations and prevent them from spreading to inappropriate areas. This includes individuals undergoing chemotherapy, those with HIV/AIDS, people taking long-term steroid medications, and patients with diabetes mellitus.

Physical trauma creates pathways for bacteria to enter deeper tissues. This can include surgical wounds, dental procedures, injuries from accidents, or medical procedures that breach the skin or mucous membranes. People with chronic conditions such as diabetes-related foot ulcers have been found to harbor Peptostreptococcus species more frequently than healthy individuals.[1]

Chronic infections of various body sites predispose to Peptostreptococcus involvement. For instance, people with chronic ear infections, persistent sinus problems, ongoing dental disease, or long-standing respiratory conditions are more susceptible. Human-to-human transmission can occur through bite wounds, meaning bites from infected individuals pose a transmission risk.[6]

Animal bites also present a risk, as transmission of the bacterium to humans via dog and cat bites has been reported. This represents a zoonotic transmission route, where bacteria move from animals to humans.[6]

Symptoms and Clinical Presentations

Although anaerobic cocci can be isolated from infections at all body sites, a predisposition for certain sites has been observed. In general, Peptostreptococcus species, particularly P. magnus, have been recovered more often from subcutaneous and soft tissue abscesses and diabetes-related foot ulcers than from intra-abdominal infections.[1]

Central Nervous System Infections

Anaerobic gram-positive cocci and microaerophilic streptococci can be isolated from meningitis (inflammation of the membranes surrounding the brain and spinal cord), cerebritis (inflammation of brain tissue), and various types of intracranial abscesses including subdural empyema, epidural abscess, and brain abscess. These serious infections develop as sequelae of chronic infections of the ears, mastoid (bone behind the ear), sinuses, and teeth.[1]

These bacteria have been isolated from 10 to 46 percent of brain abscesses studied, demonstrating their significant role in these severe infections. Peptostreptococcus anaerobius specifically has been associated with infections of the brain, demonstrating the bacteria’s ability to cause life-threatening conditions when they reach the central nervous system.[1][6]

Upper Respiratory Tract and Dental Infections

The high rate of anaerobic cocci colonization of the oropharynx (the middle part of the throat) accounts for the organisms’ significance in upper respiratory infections. These bacteria are often recovered from both acute and chronic upper respiratory tract infections and their complications.[1]

Specific recovery rates include: 9 to 38 percent of patients with chronic otitis media (middle ear infection), 15 percent of patients with chronic mastoiditis, 30 percent of patients with chronic sinusitis, 33 percent of patients with peritonsillar and retropharyngeal abscesses, and 50 percent of patients with purulent parotitis (pus-forming infection of the salivary gland). These organisms have accounted for two thirds of isolates from periodontal abscesses and are also found in acute necrotizing gingivitis.[1]

In more than 90 percent of cases, other organisms also present in the oral flora have been found mixed with anaerobic gram-positive cocci and microaerophilic streptococci. These accompanying organisms include Staphylococcus aureus, Streptococcus species, Fusobacterium species, and pigmented Prevotella and Porphyromonas species.[1]

Lung and Chest Infections

Anaerobic gram-positive cocci and microaerophilic streptococci account for 10 to 20 percent of anaerobic isolates recovered from properly obtained specimens of pulmonary infections. The lung infections in which these organisms have been found most frequently include aspiration pneumonia (pneumonia caused by breathing foreign material into the lungs), empyema associated with aspiration pneumonia (pus in the space surrounding the lungs), lung abscesses, and mediastinitis (infection of the chest cavity).[1]

Abdominal Infections

Because anaerobic gram-positive cocci are part of the normal gastrointestinal flora, they can be isolated in approximately 20 percent of specimens from intra-abdominal infections, such as peritonitis (inflammation of the abdominal lining) and abscesses of the liver, spleen, and abdomen. These bacteria are generally recovered mixed with other organisms of intestinal origin that include Escherichia coli, Bacteroides fragilis group, and Clostridium species.[1]

Female Pelvic Infections

Anaerobic gram-positive cocci and microaerophilic streptococci can be isolated in 25 to 50 percent of patients with endometritis (infection of the uterine lining), pyoderma (skin infection with pus), pelvic abscess, Bartholin gland abscess, postsurgical pelvic infections, or pelvic inflammatory disease. Peptostreptococcus anaerobius has been specifically associated with infections of the pelvic and urogenital regions.[1][6]

Skin and Soft Tissue Infections

Peptostreptococcus can cause generalized necrotizing soft tissue infections, which are severe infections that destroy tissue. These bacteria are frequently found in superficial and soft tissue infections, musculoskeletal infections, and various types of abscesses throughout the body.[2][6]

Other Serious Manifestations

These bacteria can also cause endocarditis (infection of the heart valves), though rarely, as well as puerperal fever (infection following childbirth). Peptostreptococcus anaerobius has been associated with infections of the ear, jaw, pleural cavity (space around the lungs), external genitalia, abdominal region, nasal septum, and gastrointestinal abscesses, as well as gingivitis and periodontitis (gum diseases).[6]

Prevention Strategies

Preventing Peptostreptococcus infections involves maintaining the body’s natural defenses and avoiding situations that allow normal bacterial populations to become harmful invaders. Since these bacteria are part of the normal human flora, complete avoidance is neither possible nor desirable. Instead, prevention focuses on maintaining healthy barriers and immune function.

Good oral hygiene plays a crucial role in preventing upper respiratory and dental infections. Regular tooth brushing, flossing, and professional dental care help control bacterial populations in the mouth and prevent the chronic dental infections that can serve as sources for more serious infections. Addressing dental problems promptly before they become chronic reduces the risk of bacteria spreading to deeper tissues.

Proper wound care is essential for preventing skin and soft tissue infections. Any break in the skin, whether from injury or surgery, should be cleaned promptly and thoroughly with soap and water. Keeping wounds clean and covered with appropriate dressings helps prevent bacteria from entering deeper tissues. People with diabetes should pay particular attention to foot care, as diabetes-related foot ulcers are known sites where Peptostreptococcus species are commonly found.

For people undergoing dental or oral surgery, preventive antibiotic treatment may be recommended in certain circumstances. Penicillin or metronidazole prophylaxis after dental or oral surgery may reduce the risk of bacteremia (bacteria in the bloodstream).[6][20]

Maintaining overall immune system health through proper nutrition, adequate sleep, stress management, and management of chronic conditions like diabetes helps the body maintain control over its normal bacterial populations. People with conditions that weaken the immune system should work closely with their healthcare providers to monitor for signs of infection and address them promptly.

⚠️ Important
There is no vaccine available to prevent Peptostreptococcus infections. Unlike some bacterial diseases that can be prevented through immunization, protection against these infections relies on maintaining good hygiene practices, proper wound care, and keeping the immune system healthy through overall wellness practices.

How the Body Changes During Infection

When Peptostreptococcus bacteria cause infection, several changes occur in the affected tissues and throughout the body. Understanding these changes helps explain why symptoms develop and why treatment is necessary. The pathophysiology (the functional changes associated with disease) of Peptostreptococcus infection involves complex interactions between the bacteria and the body’s tissues.

Peptostreptococcus organisms are part of the normal flora of human mucocutaneous surfaces, including the mouth, intestinal tract, vagina, urethra, and skin. When conditions allow these bacteria to breach normal barriers and invade deeper tissues, they can cause infections in body sites where they don’t normally reside.[3]

Many of the infections caused by these bacteria are synergistic, meaning the presence of Peptostreptococcus enhances the disease-causing ability of other bacteria, and vice versa. Bacterial synergy is determined by mutual induction of increased disease severity, increased mortality, increased ability to induce abscesses, and enhancement of the growth of the bacterial components in mixed infections. This synergy is found between anaerobic gram-positive cocci and their aerobic and anaerobic bacterial partners.[3]

During infection, the bacteria multiply in tissues where oxygen levels are low or absent. This multiplication triggers an immune response, with white blood cells rushing to the site to combat the infection. This inflammatory response causes swelling, redness, warmth, and pain in the affected area. When infections involve deep tissues or organs, the inflammatory response can lead to abscess formation, where pus accumulates in a contained space.

In severe cases, the bacteria can enter the bloodstream, leading to bacteremia. This allows the organisms to spread throughout the body, potentially seeding infections in distant organs. When bacteria produce toxins or when the immune response becomes overwhelming, patients can develop systemic symptoms like fever, rapid heart rate, low blood pressure, and confusion.

The anaerobic environment preferred by Peptostreptococcus means these infections often develop in areas with poor blood supply, where oxygen delivery is limited. This characteristic makes treating these infections challenging, as antibiotics depend on good blood flow to reach the infection site. Additionally, the lack of oxygen in infected tissues creates an environment where necrotic (dead) tissue can accumulate, further facilitating bacterial growth.

In chronic infections, the ongoing bacterial presence and inflammatory response can lead to tissue destruction and scarring. For example, in chronic dental infections, the bacteria contribute to the destruction of the structures supporting teeth. In chronic sinus infections, they contribute to persistent inflammation and damage to the sinus lining.

Ongoing Clinical Trials on Peptostreptococcus infection

References

https://emedicine.medscape.com/article/225140-clinical

https://en.wikipedia.org/wiki/Peptostreptococcus

https://emedicine.medscape.com/article/225140-overview

https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540426/all/Peptostreptococcus_spp___and_Finegoldia_magna_

https://pubmed.ncbi.nlm.nih.gov/34626800/

https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/peptostreptococcus.html

https://www.dwscientific.com/blog/bacterium-spotlight-peptostreptococcus-anaerobius

https://emedicine.medscape.com/article/225140-treatment

https://emedicine.medscape.com/article/225140-medication

https://www.droracle.ai/articles/136874/list-of-antibiotics-that-treats-peptostreptococcus

https://pmc.ncbi.nlm.nih.gov/articles/PMC1891013/

https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540426/all/Peptostreptococcus_spp___and_Finegoldia_magna_

https://pubmed.ncbi.nlm.nih.gov/34626800/

https://globalrph.com/bacteria/peptostreptococcus-species/

https://en.wikipedia.org/wiki/Peptostreptococcus

https://emedicine.medscape.com/article/225140-treatment

https://www.cdc.gov/group-a-strep/prevention/index.html

https://my.clevelandclinic.org/health/diseases/5911-group-a-streptococcal-infections

https://www.health.ny.gov/diseases/communicable/streptococcal/group_a/fact_sheet.htm

https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/peptostreptococcus.html

https://www.mayoclinic.org/diseases-conditions/strep-throat/diagnosis-treatment/drc-20350344

https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540426/all/Peptostreptococcus_spp___and_Finegoldia_magna_

https://myhealth.alberta.ca/Health/aftercareinformation/pages/conditions.aspx?hwid=uh3916

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

Can Peptostreptococcus infection spread from person to person?

Yes, human-to-human transmission can occur through bite wounds. However, since Peptostreptococcus is part of the normal flora in healthy people, casual contact doesn’t typically spread disease. The bacteria need a portal of entry, such as broken skin, to cause infection in another person.

How long does it take for symptoms to appear after exposure to Peptostreptococcus?

The incubation period for Peptostreptococcus infections is unknown. This is partly because these bacteria are already present in the body as normal flora, making it difficult to determine when they transition from harmless inhabitants to disease-causing organisms.

Are Peptostreptococcus infections more dangerous than other bacterial infections?

While most Peptostreptococcus infections cause relatively mild illnesses, they can lead to serious complications like brain abscesses, lung infections, and blood poisoning. The bacteria’s tendency to cause mixed infections with other organisms and their increasing resistance to some antibiotics can complicate treatment.

What antibiotics work best against Peptostreptococcus?

Penicillin G is most effective for treating anaerobic gram-positive cocci including Peptostreptococcus. Other effective agents include other penicillins, cephalosporins, clindamycin, vancomycin, and carbapenems. However, the efficacy of macrolides and metronidazole is variable and unpredictable, with metronidazole being ineffective against some anaerobic gram-positive cocci.

Can you have Peptostreptococcus in your body without being sick?

Absolutely. Peptostreptococcus species are commensal organisms that normally live in the mouth, skin, gastrointestinal tract, vagina, and urinary tracts of healthy people. They only cause problems when circumstances change, such as when the immune system is weakened or when tissue injury allows them access to areas where they don’t belong.

🎯 Key takeaways

  • Peptostreptococcus bacteria live peacefully in healthy bodies as part of normal flora, only causing disease when barriers break down or immunity weakens
  • These bacteria account for about one quarter of all anaerobic infections, making them the second most frequently recovered anaerobic organisms in clinical practice
  • Peptostreptococcus infections rarely occur alone, typically partnering with other bacteria in synergistic relationships that enhance disease severity
  • The bacteria can infect virtually any body site but show preference for subcutaneous tissues, soft tissue abscesses, and diabetes-related foot ulcers
  • Proper wound care, good oral hygiene, and maintaining immune system health form the cornerstone of prevention since no vaccine exists
  • Penicillin remains the most effective antibiotic, though treatment often requires broader coverage to address the mixed bacterial populations involved
  • Surgical drainage combined with antibiotics may be necessary for abscesses, as medications alone cannot always reach bacteria in poorly oxygenated tissues
  • Animal bites from dogs and cats can transmit Peptostreptococcus to humans, representing an important zoonotic transmission route